Suzhou Basecare Medical Corporation Limited
HKEX:2170.HK
1.33 (HKD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q3 | 2019 Q4 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| -140.785 | -69.405 | -110.629 | -40.079 | -123.435 | -50.508 | -28.794 | 0 | -160.854 |
| Depreciation & Amortization
| 14.925 | 6.505 | 4.278 | 4.453 | 3.368 | 3.363 | 1.182 | 0 | 2.284 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 0 | 0 | 0 | 0 | 0 | 0 | 2.964 | 0 | -3.18 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 2.28 | 0 | -1.459 |
| Change In Accounts Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 0 | 0 | 0 | 0 | 0 | 0 | 0.684 | 0 | -1.721 |
| Other Non Cash Items
| 19.669 | -38.144 | 9.661 | -59.483 | -14.858 | -24.249 | 7.463 | 0 | 157.88 |
| Operating Cash Flow
| -136.041 | -114.054 | -105.246 | -104.015 | -141.662 | -78.121 | -17.185 | -19.572 | -3.87 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -55.139 | -57.441 | -61.765 | -82.704 | -27.569 | -17.044 | -3.145 | -1.965 | -0.514 |
| Acquisitions Net
| 6.018 | -281.656 | 62.679 | -38.931 | 0.431 | 0 | 14.5 | 2.736 | 0 |
| Purchases Of Investments
| 0.08 | -1.778 | -56.688 | -30.188 | 0 | 0 | 0 | 0 | -70 |
| Sales Maturities Of Investments
| 0 | 0 | 84.62 | 0 | 0 | 0 | 0 | 0 | 81.414 |
| Other Investing Activites
| 0 | -0 | -0 | -0 | -51.358 | 6.12 | -5.05 | 1.721 | 0.013 |
| Investing Cash Flow
| -49.041 | -340.875 | 28.846 | -151.823 | -78.496 | -10.924 | 6.305 | 2.492 | 10.913 |
| Financing Activities: | |||||||||
| Debt Repayment
| -47.759 | -164.784 | -28.979 | -4.401 | -28.514 | -11.999 | 0 | -10 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 133.636 | 1,897.671 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0 | -3.031 | -1.234 | 0 | -111.882 | 0 | 0 | 218.033 | 0 |
| Financing Cash Flow
| 45.363 | 161.753 | 27.746 | 1.887 | 48.435 | 1,884.032 | -13.652 | 208.033 | 4.073 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| 0 | -16.689 | -23.678 | -60.577 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -146.21 | -309.864 | -72.332 | -314.527 | -145.284 | 1,794.987 | -33.085 | 190.953 | 11.116 |
| Cash At End Of Period
| 1,039.579 | 1,185.789 | 1,495.653 | 1,567.986 | 1,882.513 | 2,027.797 | 192.321 | 225.406 | 24.155 |